CARDIAC MYOSIN ACTIVATOR CKINCREASES MYOFIBRIL ATPASE ACTIVITY MYOCYTE CONTRACTILITY AND

First Page		Document Content
Date: 2008-03-07 11:41:50 Skeletal muscle Cytoskeleton Proteins Cardiovascular physiology Myosin Sarcomere Heart failure Inotrope Omecamtiv Mecarbil Biology Anatomy Muscular system		CARDIAC MYOSIN ACTIVATOR CKINCREASES MYOFIBRIL ATPASE ACTIVITY MYOCYTE CONTRACTILITY AND Add to Reading List Source URL: www.cytokinetics.com Download Document from Source Website File Size: 388,56 KB Share Document on Facebook

	HEART FAILURE DISEASE FACT SHEET AND OPPORTUNITY FOR OMECAMTIV MECARBIL What is heart failure About Us Cytokinetics is a clinical-stage biopharmaceutical company focused on the discovery and development of novel small DocID: 141u6 - View Document
	150219_CYTK_FactSheet_Med DocID: 140Ws - View Document
	BIOTECH’S MOST RESPECTED NEWS SOURCE FOR MORE THAN 20 YEARS TM WEDNESDAY JUNE 26, 2013 DocID: 13Lid - View Document
$Cardiology / Heart failure / Cardiac output / Ejection fraction / Blood pressure / Stroke volume / Omecamtiv Mecarbil / Pressure-volume loop analysis in cardiology / Cardiovascular physiology / Circulatory system / Anatomy$	FIRST CLINICAL TRIAL OF THE SELECTIVE CARDIAC MYOSIN ACTIVATOR, CK, DocID: 13BUF - View Document
	The Cardiac Myosin Activator, CK1122534, Increases Contractility in Adult Cardiac Myocytes But Does Not Affect the Calcium Transient or Depend on Second Messenger Signaling Congrong Niu, Robert L Anderson, David R Cox, B DocID: 13xjk - View Document